Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.43 |
| ▸ | SQLE | Q14534 | 6/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Myrcene SCHEMBL21622 | 0.80 | TSHR (1.00) | TSHRKMT2AKDM4EATMALOX15 | |
| Myrcene SCHEMBL3987529 | 0.80 | TSHR (1.00) | TSHRKMT2AKDM4EATMALOX15 | |
| Myrcene SCHEMBL1867602 | 0.80 | TSHR (1.00) | TSHRKMT2AKDM4EATMALOX15 | |
| SCHEMBL28649807 | 0.79 | TSHR (0.53) | TSHRKMT2AKDM4EATMALOX15 | |
| Myrcene SCHEMBL9709428 | 0.78 | TSHR (0.95) | TSHRKMT2AKDM4EATMALOX15 | |
| Myrcene SCHEMBL11291940 | 0.78 | TSHR (0.95) | TSHRKMT2AKDM4EATMALOX15 | |
| Myrcene SCHEMBL28396515 | 0.78 | TSHR (0.95) | TSHRKMT2AKDM4EATMALOX15 | |
| Myrcene SCHEMBL11311399 | 0.78 | TSHR (0.95) | TSHRKMT2AKDM4EATMALOX15 | |
| Myrcene SCHEMBL7011582 | 0.78 | TSHR (0.95) | TSHRKMT2AKDM4EATMALOX15 | |
| Myrcene SCHEMBL9709867 | 0.78 | TSHR (0.95) | TSHRKMT2AKDM4EATMALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4168383-B1 | PROCESS FOR MAKING A CONJUGATED DIENE FROM AN ALLYL ALCOHOL | GIVAUDAN SA (CH) | 2024-07-31 | — | — | EP | claimed |
| US-20230322645-A1 | PROCESS FOR MAKING A CONJUGATED DIENE FROM AN ALLYL ALCOHOL | GIVAUDAN SA (CH) | 2023-10-12 | — | — | US | claimed |
| EP-4168383-A1 | PROCESS FOR MAKING A CONJUGATED DIENE FROM AN ALLYL ALCOHOL | Givaudan SA (CH) | 2023-04-26 | — | — | EP | claimed |
| CN-115996904-A | Process for preparing conjugated dienes from allyl alcohol | 奇华顿股份有限公司 | 2023-04-21 | — | — | CN | claimed |
| EP-4168383-A1 | PROCESS FOR MAKING A CONJUGATED DIENE FROM AN ALLYL ALCOHOL | Givaudan SA (CH) | 2023-04-26 | — | — | EP | disclosed |
| CN-115996904-A | Process for preparing conjugated dienes from allyl alcohol | 奇华顿股份有限公司 | 2023-04-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322645-A1 | PROCESS FOR MAKING A CONJUGATED DIENE FROM AN ALLYL ALCOHOL | ADH1C, ADH1A, ADH5 | TSHR 2518/4885KMT2A 1850/4885KDM4E 2909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.